Doxepin Hydrochloride

Insomnia, Neurotic depression, Depression + 8 more

Treatment

20 Active Studies for Doxepin Hydrochloride

What is Doxepin Hydrochloride

Doxepin

The Generic name of this drug

Treatment Summary

Doxepin is a medication used to treat anxiety and depression. It works by blocking certain receptors in the brain to reduce feelings of anxiety and depression. It is similar to other medications in its class, such as amitriptyline, clomipramine, desipramine, imipramine, nortriptyline, protriptyline, and trimipramine. Doxepin was originally developed by Pfizer and approved by the FDA in 1969 as an antidepressant, but it was later approved in 2010 for the treatment of insomnia.

Sinequan

is the brand name

image of different drug pills on a surface

Doxepin Hydrochloride Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Sinequan

Doxepin

1969

307

Effectiveness

How Doxepin Hydrochloride Affects Patients

Doxepin is a type of antidepressant that is known to cause antidepressant, sedative, and anticholinergic effects. It works by decreasing the electrical activity of the brain and is usually prescribed to treat insomnia or anxiety. The antidepressant effects start to take effect after two weeks, while the sedative effects are felt right away. High doses of doxepin can cause central nervous system depression and limit its effectiveness due to its antiadrenergic and anticholinergic properties.

How Doxepin Hydrochloride works in the body

Doxepin works by blocking histamine receptors and increasing the amount of certain chemicals in the brain. This helps to reduce anxiety and depression by increasing activity at the nerve cell receptor sites, desensitizing serotonin and beta-adrenergic receptors, and increasing dopamine transmission in the frontal cortex.

When to interrupt dosage

The suggested dosage of Doxepin Hydrochloride is contingent upon the diagnosed condition, such as Depression, Involutional, Mental Disorder, Organic and Insomnia. The amount of dosage likewise deviates as per the approach of delivery (e.g. Oral or Tablet - Oral) outlined in the table beneath.

Condition

Dosage

Administration

Insomnia

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Neurotic depression

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Depression

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Generalized Anxiety Disorder

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Neuropathic Pain

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Itching

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Depressive Disorder, Major

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Behcet Syndrome

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Alcoholism

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Depressive Disorder, Major

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Neurodermatitis

, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %

Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule, Capsule - Oral, Topical, Cream - Topical, Cream, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated - Oral, Tablet, film coated

Warnings

Doxepin Hydrochloride Contraindications

Condition

Risk Level

Notes

untreated narrow angle glaucoma

Do Not Combine

Pulse Frequency

Do Not Combine

Urinary Retention

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Doxepin may interact with Pulse Frequency

There are 20 known major drug interactions with Doxepin Hydrochloride.

Common Doxepin Hydrochloride Drug Interactions

Drug Name

Risk Level

Description

4-Methoxyamphetamine

Major

Doxepin may increase the vasopressor activities of 4-Methoxyamphetamine.

Acepromazine

Major

Doxepin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.

Aclidinium

Major

The risk or severity of adverse effects can be increased when Doxepin is combined with Aclidinium.

Alfuzosin

Major

Doxepin may increase the hypotensive activities of Alfuzosin.

Aripiprazole

Major

Doxepin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.

Doxepin Hydrochloride Toxicity & Overdose Risk

The highest toxic dose of doxepin in mice and rats has been found to be 180mg/kg and 147mg/kg, respectively. Overdosing on doxepin can cause seizures, irregular heart rhythms, loss of consciousness, low blood pressure, and depression of the central nervous system. Studies have also shown that doxepin can affect fertility, causing an increase in the copulatory interval, decrease in the number of viable embryos, and reduction in sperm motility. There is no evidence suggesting doxepin can cause cancer or mutations.

image of a doctor in a lab doing drug, clinical research

Doxepin Hydrochloride Novel Uses: Which Conditions Have a Clinical Trial Featuring Doxepin Hydrochloride?

1020 active clinical trials are in progress to analyze the potential of Doxepin Hydrochloride in providing symptom relief for Generalized Anxiety Disorder, Atopic Dermatitis and Bipolar Disorder.

Condition

Clinical Trials

Trial Phases

Generalized Anxiety Disorder

174 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Early Phase 1, Phase 3, Phase 1

Depressive Disorder, Major

0 Actively Recruiting

Insomnia

0 Actively Recruiting

Depression

290 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3

Alcoholism

7 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Neurotic depression

0 Actively Recruiting

Depressive Disorder, Major

0 Actively Recruiting

Itching

3 Actively Recruiting

Phase 3, Not Applicable

Behcet Syndrome

1 Actively Recruiting

Not Applicable

Neuropathic Pain

4 Actively Recruiting

Not Applicable, Phase 1, Phase 2

Neurodermatitis

0 Actively Recruiting

Doxepin Hydrochloride Reviews: What are patients saying about Doxepin Hydrochloride?

4.7

Patient Review

9/4/2020

Doxepin Hydrochloride for Chronic Trouble Sleeping

This medication is older, but it still helps me sleep.

4.3

Patient Review

3/10/2020

Doxepin Hydrochloride for Anxiousness associated with Depression

This drug is effective at helping me stay asleep, though it can take a little while to feel the effects. I usually take it two hours before bed. It also helps a bit with anxiety, but if that's your main goal there are probably better options out there.

4.3

Patient Review

3/24/2019

Doxepin Hydrochloride for Chronic Trouble Sleeping

I use this medication to help with my depression, anxiety, and fibromyalgia. I find that it works great most nights, but sometimes I'll wake up during the night. Overall, though, I sleep much better with this medication than without it.

4.3

Patient Review

10/23/2022

Doxepin Hydrochloride for Anxiousness associated with Depression

This medication has been excellent for my anxiety. I take it twice a day at 50mg each and it makes me feel calmer without the euphoria. Additionally, it's helped curb my more psychopathic tendencies without having to resort to antipsychotics.

4.3

Patient Review

8/30/2022

Doxepin Hydrochloride for Chronic Trouble Sleeping

Doxepin has been a lifesaver for me when it comes to insomnia. It's helped me get more restful sleep and I only need to take a break from it every few days or so to prevent tolerance. I haven't experienced many negative side effects, which is great.

4

Patient Review

5/16/2018

Doxepin Hydrochloride for Anxiousness associated with Depression

Used to help with anxiety and falling asleep.

2.3

Patient Review

9/15/2017

Doxepin Hydrochloride for Chronic Trouble Sleeping

I was prescribed this to help with my insomnia and depression, with the eventual goal of replacing Klonipin. However, I had a very severe reaction to it in the form of abnormal heartbeats. I had to be monitored overnight at the hospital to make sure there was no lasting damage done. Needless to say, I am off of this medication now and feel much better for it.

2.3

Patient Review

2/22/2019

Doxepin Hydrochloride for Chronic Trouble Sleeping

Maybe the 25mg dosage just isn't enough for someone of my size. Additionally, I may have a natural resistance to anesthesia that this drug is ineffective against. As such, I remain sleep deprived.

2

Patient Review

1/15/2022

Doxepin Hydrochloride for Depression

Before I started this medication, I was managing my depression well. However, since starting it my mood has plummeted. Additionally, seizures are a possible side effect of this drug and my doctor still prescribed it to me even though he knows I have epilepsy.

1.7

Patient Review

4/8/2022

Doxepin Hydrochloride for Chronic Trouble Sleeping

I've been on this medication for about a year now. Before this, I was taking trazadone which didn't help me at all. They put me on this when I was 12, but after three months they had to lower the dosage because it made me too tired all the time. If you ask me, it's just been one big mess with my meds ever since I first started seeing doctors for this stuff.

1.3

Patient Review

3/26/2018

Doxepin Hydrochloride for Anxious

I started taking this drug a few years ago and have since gained 35-40 pounds. I'm stopping the medication as of yesterday in the hopes that I will lose the weight. I originally started taking it because I was struggling with anxiety after my son passed away, but I am hopeful that I will be okay without it.

1

Patient Review

4/10/2022

Doxepin Hydrochloride for Itching

I took 75mg at bedtime and it really messed me up. I slept a lot, but the next day I felt groggy and unable to function properly. Be careful with this drug, as the side effects are not worth it.

1

Patient Review

6/20/2022

Doxepin Hydrochloride for Anxiousness associated with Depression

I tried this medication for one week and it completely disrupted my sleep schedule. I was groggy and exhausted all day, and only woke up for a few hours in the middle of the night. I also gained four pounds. Overall, this made my anxiety worse instead of better.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about doxepin hydrochloride

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Doxepin Hydrochloride used for?

"This medicine is available only with your doctor's prescription

Doxepin can be used to treat anxiety, depression, or insomnia. It is a tricyclic antidepressant (TCA) that works on the central nervous system (CNS) by increasing levels of certain chemicals in the brain. A prescription from a doctor is required in order to purchase this medication."

Answered by AI

Is doxepin a narcotic?

"Doxepin is not classified as a controlled substance by the Drug Enforcement Administration and thus has a low risk for abuse."

Answered by AI

Can doxepin hydrochloride get you high?

"Doxepin can be used to help with symptoms that are linked to anxiety and depression. These symptoms may include fear, guilt, sleep problems, tension, and worry. Doxepin does not have any Euphoric effect and is not associated with dependence or tolerance. However, the most common side effects are drowsiness when starting treatment and weight gain."

Answered by AI

Will doxepin help me sleep?

"Doxepin is a medication used to treat insomnia. It is part of a class of medications called tricyclic antidepressants. These medications work by slowing activity in the brain to allow sleep."

Answered by AI

Clinical Trials for Doxepin Hydrochloride

Have you considered Doxepin Hydrochloride clinical trials?

We made a collection of clinical trials featuring Doxepin Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of Western Psychiatric Hospital/University of Pittsburgh in Pittsburgh, United States.

Sleep and Circadian Interventions for Suicide

18 - 25
All Sexes
Pittsburgh, PA

The purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators will evaluate three interventions targeting sleep in acutely suicidal college students enrolled in intensive outpatient treatment. Participants will be randomly assigned to one of three intervention groups: 1. Triple Chronotherapy (TCT)+ Transdiagnostic Sleep and Circadian Intervention (TSC) 2. Transdiagnostic Sleep and Circadian Intervention (TSC) 3. Sleep Feedback (SF) Participants will be followed for 6 months with primary outcome domains of suicidal thoughts and behaviors and depression evaluated by blinded clinicians at short (Days 1-4 of intervention), medium (2 months) and long (6 month) term intervals.

Waitlist Available
Has No Placebo

Western Psychiatric Hospital/University of Pittsburgh

Tina Goldstein, PhD

Image of University of South Florida in Tampa, United States.

WeACT Program for Caregivers of People With Dementia

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to learn whether WeACT, a self-paced, web-based program, is feasible and helpful for adult family caregivers of a relative living with dementia. WeACT is based on acceptance and commitment therapy (ACT), which teaches skills to handle difficult thoughts and feelings and take steps toward what matters most. The main questions this study aims to answer are: * Can caregivers complete WeACT as planned? * Do caregivers show improvements in mental health and coping after using WeACT? * What are caregivers' experiences with the program, and what suggestions do they have to improve it? Participants will: * Complete six self-paced weekly online modules and use the daily practice section during the program. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experience.

Waitlist Available
Has No Placebo

University of South Florida

Areum Han

Image of Fred Hutch/University of Washington Cancer Consortium in Seattle, United States.

Psilocybin Therapy for Anxiety and Depression in Cancer

18 - 85
All Sexes
Seattle, WA

This phase II trial tests the safety, side effects and how well group retreat psilocybin therapy works for the treatment of anxiety and depression in patients with solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic) or with hematologic cancers for which no treatment is currently available (incurable). For patients with metastatic, incurable cancer, unrelieved anxiety and existential distress can cause profound suffering. Psilocybin therapy can relieve anxiety and existential distress by disrupting patterns of thinking that contribute to anxiety and depression. Psilocybin is a substance being studied in the treatment of anxiety or depression in patients with cancer. In this study, a pharmaceutical grade of psilocybin will be used that has been approved by the FDA for research, provided by Filament Health. Psilocybin acts on the brain by resetting the brain's activity and increasing connections between brain regions, particularly those involved in mood regulation and self-perception. In this study psilocybin is combined with structured discussions and reflections that enable patients to have new insights about their situation. In a prior study, group retreat psilocybin therapy was proven to be safe and this study tests a refined dosing regimen for symptoms of anxiety and depression in patients with metastatic solid tumors or incurable hematologic malignancies.

Phase 2
Waitlist Available

Fred Hutch/University of Washington Cancer Consortium

Anthony Back, MD

Image of Wahwala Iyohlogya/Peaceful Means in Pine Ridge, United States.

Lakota Family Acceptance Program for Depression and Anxiety

Any Age
All Sexes
Pine Ridge, SD

The goal of this open pilot trial (OPT) is to develop a Lakota-adapted Family Acceptance Project (LFAP) for Indigenous 2SLGBTQ+ youth and their caregivers. The OPT is specifically focused on acceptability, feasibility, and safety of programming and research protocols. The investigators will also examine pre- to post- changes on outcomes for the sole purposes of making sure scores on measures are changing in the hypothesized direction (e.g., depression scores are going from moderate to minimal as opposed to no change or depression scores increasing). Once enrolled in the study, participants complete a baseline survey. Then participants will engage in LFAP which is an 8-session group intervention; sessions will be scheduled once a week for eight weeks (at 2 hours per session). Participants will complete survey instruments before and immediately after the program sessions, in addition to post-program surveys and an exit interview.

Recruiting
Has No Placebo

Wahwala Iyohlogya/Peaceful Means (+1 Sites)

Katie Edwards, PhD

Have you considered Doxepin Hydrochloride clinical trials?

We made a collection of clinical trials featuring Doxepin Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of Seaway Valley Community Health Centre (Cardiac Rehab Program) in Cornwall, Canada.

FRAME for Heart Failure

18+
All Sexes
Cornwall, Canada

Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives. Despite this interconnection, the integration of mental health awareness and support into cardiac care remains limited. To address this gap, the FRAME (Foundation, Recognition, Awareness, Management, Engagement) intervention was co-designed by researchers, healthcare providers, health system decisionmakers, and patient partners. This pilot study evaluates the feasibility of implementing the FRAME intervention in pilot clinical sites within two health regions in Ontario, Canada, including team-based family medicine clinics, cardiac rehabilitation/specialist clinics, and emergency departments. Utilizing a pretest-posttest hybrid 1 model intervention design, this study evaluates process indicators and patient-focused outcomes through surveys and semi-structured qualitative interviews. Findings from this study will inform a future large scale cohort study and scalable integration of the FRAME tool into existing cardiac care pathways to enhance mental health awareness and support among heart failure patients.

Recruiting
Has No Placebo

Seaway Valley Community Health Centre (Cardiac Rehab Program) (+8 Sites)

Image of Fort Bend ISD in Sugar Land, United States.

Wellbeing Interventions for Anxiety

10 - 20
All Sexes
Sugar Land, TX

The goal of this clinical trial is to learn if psychology and music based interventions can impact anxiety and overall wellbeing in adolescents enrolled in choral music classes. The main questions it aims to answer are: Do specific psychology and music based breathing interventions impact anxiety and overall wellbeing in adolescents? Do specific psychology and music based performance anxiety reduction interventions impact anxiety and overall wellbeing in adolescents? Do specific psychology and music based emotion regulation interventions impact anxiety and overall wellbeing in adolescents? Researchers will compare results of pre-test data, post-test data, qualitative interviews, and surveys of adult choral directors to see if there is a measurable impact on adolescent anxiety and overall wellbeing. Participants will: * Use box breathing during choral music warm-ups to connect choral breathing to breathing for anxiety reduction * Use "magnify" technique to compare cognitive distortions regarding an upcoming performance that may cause anxiety to the most likely realistic outcome * Use emotion regulation through song lyrics technique to connect lyrics of choral music repertoire to participants experienced emotions

Waitlist Available
Has No Placebo

Fort Bend ISD

Jane Kuehne, PhD

Have you considered Doxepin Hydrochloride clinical trials?

We made a collection of clinical trials featuring Doxepin Hydrochloride, we think they might fit your search criteria.
Go to Trials